Status: Recruiting
A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease
An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
Participants needed: 7
Trial details
Phase: Early Phase 1Age: 12+Biological sex: AllType: InterventionalSponsor: Krystal Biotech, Inc.Updated: Jul 21, 2026Locations: 1
Eligibility criteria
The participant must have read, understood, and signed an Institutional Review B... [+5]
Participation in another clinical study or treatment with an investigational age... [+4]